Managers / Q1 2025 · view latest →
NVP Associates, LLC
CIK 0001545692 · 1300 EL CAMINO REAL, SUITE 200, MENLO PARK, CA, 94025 · 650-321-8000
Summary
Nvp Associates, LLC reported $112M in U.S.-listed holdings across 6 positions for Q1 2025.
The portfolio is heavily concentrated: DAVE alone accounts for 42.9% of reported value.
Compared with Q4 2024, the fund opened 0 new positions and exited 1.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 100.0% · $112M
Quarter-over-Quarter Changes full breakdown →
vs Q4 2024 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| 7WHUDEMY INC | SOLD OUT | −3.11M | 0 | −$26M | $0 |
| TALKTALKSPACE INC | TRIMMED | −4.90M | 9.80M | −$20M | $25M |
| GROVGROVE COLLABORATIVE HOLD INC | ADDED | +281.6K | 3.23M | +$262,385 | $4M |
| MBXMBX BIOSCIENCES INC | HELD | +0 | 2.14M | −$24M | $16M |
| DAVEDAVE INC | HELD | +0 | 582.7K | −$2M | $48M |
| OPENOPENDOOR TECHNOLOGIES INC | HELD | +0 | 4.19M | −$2M | $4M |
| ZBIOZENAS BIOPHARMA INC | HELD | +0 | 1.84M | −$533,160 | $15M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2025
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | DAVEDAVE INChistory → | CLASS A COM NEW | 42.94% | $48M | 582.7K |
| 2 | TALKTALKSPACE INChistory → | COM | 22.37% | $25M | 9.80M |
| 3 | MBXMBX BIOSCIENCES INChistory → | COM | 14.05% | $16M | 2.14M |
| 4 | ZBIOZENAS BIOPHARMA INChistory → | COM | 12.95% | $15M | 1.84M |
| 5 | GROVGROVE COLLABORATIVE HOLD INChistory → | COM CL A | 3.88% | $4M | 3.23M |
| 6 | OPENOPENDOOR TECHNOLOGIES INChistory → | COM | 3.81% | $4M | 4.19M |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $176M | 5 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $255M | 6 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $166M | 5 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $184M | 7 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $112M | 6 | May 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $187M | 7 | Feb 10, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $176M | 8 | Nov 12, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $91M | 6 | Aug 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $126M | 6 | May 10, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $112M | 6 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $112M | 8 | Nov 8, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $115M | 9 | Aug 1, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $87M | 8 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $102M | 8 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.